Bajaj Healthcare Limited (NSE:BAJAJHCARE) — Market Cap & Net Worth
Market Cap & Net Worth: Bajaj Healthcare Limited (BAJAJHCARE)
Bajaj Healthcare Limited (NSE:BAJAJHCARE) has a market capitalization of $125.29 Million (Rs11.59 Billion) as of September 28, 2026. Listed on the NSE stock exchange, this India-based company holds position #18413 globally and #983 in its home market, demonstrating a 4.81% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bajaj Healthcare Limited's stock price Rs344.15 by its total outstanding shares 33662661 (33.66 Million). Also see Bajaj Healthcare Limited assets under control for a full breakdown of the balance sheet.
Bajaj Healthcare Limited Market Cap History: 2021 to 2026
Bajaj Healthcare Limited's market capitalization history from 2021 to 2026. Data shows change from $149.29 Million to $125.29 Million (-0.91% CAGR). Also see Bajaj Healthcare Limited operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Bajaj Healthcare Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bajaj Healthcare Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check BAJAJHCARE stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.02x
Bajaj Healthcare Limited's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.79x
Bajaj Healthcare Limited's market cap is 0.79 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $149.29 Million | $6.56 Billion | $831.09 Million | 0.02x | 0.18x |
| 2022 | $161.06 Million | $6.79 Billion | $713.86 Million | 0.02x | 0.23x |
| 2023 | $136.52 Million | $6.46 Billion | $430.24 Million | 0.02x | 0.32x |
| 2024 | $208.75 Million | $4.73 Billion | -$837.93 Million | 0.04x | N/A |
| 2025 | $151.12 Million | $5.43 Billion | $394.95 Million | 0.03x | 0.38x |
| 2026 | $125.29 Million | $6.11 Billion | $157.66 Million | 0.02x | 0.79x |
Competitor Companies of BAJAJHCARE by Market Capitalization
Companies near Bajaj Healthcare Limited in the global market cap rankings as of September 28, 2026. Review tangible equity quality of Bajaj Healthcare Limited to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Bajaj Healthcare Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #592 globally with a market cap of $46.00 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #634 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #662 globally with a market cap of $41.87 Billion USD ( CN¥286.16 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #592 | GALDERMA GROUP AG | NYSE:GALDY | $46.00 Billion | $39.45 |
| #634 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.20 |
| #662 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $41.87 Billion | CN¥44.86 |
Bajaj Healthcare Limited Historical Marketcap From 2021 to 2026
Between 2021 and today, Bajaj Healthcare Limited's market cap moved from $149.29 Million to $ 125.29 Million, with a yearly change of -0.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs125.29 Million | -17.09% |
| 2025 | Rs151.12 Million | -27.61% |
| 2024 | Rs208.75 Million | +52.90% |
| 2023 | Rs136.52 Million | -15.24% |
| 2022 | Rs161.06 Million | +7.88% |
| 2021 | Rs149.29 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 28th, 2026 the market cap of Bajaj Healthcare Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $125.29 Million USD |
| MoneyControl | $125.29 Million USD |
| MarketWatch | $125.29 Million USD |
| marketcap.company | $125.29 Million USD |
| Reuters | $125.29 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bajaj Healthcare Limited
Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, … Read more